Get the Stockscreener App
22.35
4.81%
-1.13
After Hours:
22.35
Apollomics Inc stock is traded at $22.35, with a volume of 39,569.
It is down -4.81% in the last 24 hours and down -15.66% over the past month.
Apollomics Inc is an clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company programs include vebreltinib (APL-101), selective c-Met inhibitor for the treatment of non-small cell lung cancer and other tumors with c-Met alterations, and uproleselan (APL-106), a specific E-Selectin antagonist that has the potential to be used adjunctively with standard chemotherapy to treat acute myeloid leukemia. Company has three new immuno-oncology product candidates: APL-501, APL-502 and APL-801 include mono-specific and bi-specific antibodies to fight against cancer.
See More
Previous Close:
$23.48
Open:
$24.8
24h Volume:
39,569
Relative Volume:
1.70
Market Cap:
$65.15M
Revenue:
$8.50M
Net Income/Loss:
$-10.94M
P/E Ratio:
-2.9524
EPS:
-7.57
Net Cash Flow:
$-28.76M
1W Performance:
-4.57%
1M Performance:
-15.66%
6M Performance:
+25.07%
1Y Performance:
+21.25%
1-Day Range:
$22.00
$24.96
1-Week Range:
$21.88
$25.00
52-Week Range:
$10.01
$42.12
Apollomics Inc Stock (APLM) Company Profile
Compare APLM vs VRTX, REGN, MRNA, ARGX, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
APLM
Apollomics Inc
|
22.35 | 65.15M | 8.50M | -10.94M | -28.76M | -7.57 |
VRTX
Vertex Pharmaceuticals Inc
|
526.19 | 133.37B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
788.04 | 81.13B | 14.92B | 4.42B | 3.79B | 41.04 |
MRNA
Moderna Inc
|
198.88 | 79.40B | 2.23B | -3.19B | -1.60B | -8.1462 |
ARGX
Argen X Se Adr
|
959.49 | 60.03B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
204.97 | 43.93B | 742.00K | -1.37B | -1.07B | -7.0731 |
Apollomics Inc Stock (APLM) Latest News
Form 4 Apollomics Inc For: 24 September By Investing.com - Investing.com Nigeria
An amended Apollomics (APLM) insider report corrects an option's expiration date and accounts for 100 omitted shares. - Stock Titan
A director's 2,000 stock options expire in 2036, Apollomics (APLM) says in an amendment. - Stock Titan
Apollomics CFO acquires 10,000 shares as awards vest - Stock Titan
Price to sales forward of Apollomics Inc. – NASDAQ:APLM - TradingView
New stock awards for Apollomics (APLM) CFO - Stock Titan
New equity awards for Apollomics (APLM) director - Stock Titan
Apollomics (NASDAQ: APLM) COO now holds 20,100 shares - Stock Titan
Apollomics (APLM) director adds 500 shares via awards - Stock Titan
Apollomics (APLM) CEO adds options and 5,000 new shares - Stock Titan
Price-Driven Insight from (APLM) for Rule-Based Strategy - Stock Traders Daily
Apollomics (NASDAQ: APLM) Registers 279,775 Class A Shares for Resale by Selling Securityholders - Kalkine Media
Apollomics (APLMW) Stock Analysis Report | Financials & Insights - Benzinga España
Behavioral Patterns of APLM and Institutional Flows - Stock Traders Daily
Apollomics Inc. (APLM) Holds Steady at $27.5 as Shares Consolidate Between Key LevelsBearish Pattern Stocks - dars.gov.et
Apollomics (APLM) director gains 500 shares from RSU vesting - Stock Titan
Apollomics (APLM) Technicals: Moves 3.21% Up to $24.33 for the Current Session - dars.gov.et
Apollomics Inc. Class A Ordinary Shares (NASDAQ: APLM) Stock Price, News & Analysis - Kalkine
Insiders Of Apollomics Are Up 69% On Their US$7.95m Purchase - simplywall.st
Apollomics, Inc. announced that it has received $8.00001 million in funding from Maxpro Investment Co., Ltd. and other investors. - marketscreener.com
Biotech Apollomics (APLM) raises $10M in private offering - Stock Titan
Apollomics Company Profile & Introduction - Moomoo
Monday’s insider activity: Major buys at Cardinal, Apollomics By Investing.com - Investing.com Canada
Monday’s insider activity: Major buys at Cardinal, Apollomics - Investing.com
Apollomics Insider Bought Shares Worth $7,550,004, According to a Recent SEC Filing - marketscreener.com
Apollomics CFO Peter Lin buys $400,005 in shares By Investing.com - Investing.com Nigeria
Apollomics CFO Peter Lin buys $400,005 in shares - Investing.com
Apollomics COO Chen Yi-Kuei buys $300,000 in shares - Investing.com
Apollomics CEO Chen Hung-Wen acquires $7.55 million in stock - Investing.com
Apollomics (NASDAQ: APLM) COO adds 20K shares in private deal - Stock Titan
Apollomics (APLM) CEO has voting power over 1,029,695 shares - Stock Titan
Apollomics (APLM) CEO boosts stake with 370,000-share PIPE - Stock Titan
Liquidity Mapping Around (APLM) Price Events - Stock Traders Daily
Apollomics (APLM) details Yi‑Kuei Chen’s 4.97% stake after $300,000 share purchase - Stock Titan
Apollomics (APLM) Edges Higher to $17.37 as Biotech Momentum BuildsPrice Momentum Stocks - vinanet.vn
Apollomics (Nasdaq: APLM) lines up $10M private share placement - Stock Titan
Apollomics raises $10 million in private placement By Investing.com - Investing.com Nigeria
Apollomics raises $10 million in private placement - Investing.com
Apollomics Announces $10 Million Private Placement Transaction - GlobeNewswire
Apollomics Inc (APLM) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Enterprise value to EBITDA forward of Apollomics Inc. – NASDAQ:APLMW - TradingView
Price to earnings forward of Apollomics Inc. – NASDAQ:APLMW - TradingView
Price to book forward of Apollomics Inc. – NASDAQ:APLMW - TradingView
Apollomics Inc (APLM) Stock News Today - TradingKey
Why (APLM) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Apollomics (APLM) Advances 1.62% as Shares Hold Above $16.97 SupportVolatility Smirk - Vinanet
Apollomics Inc (APLM) Cash Flow - TradingKey
Apollomics Inc. (APLM) Holds Above Support as Stock Rises ModestlyTechnical Analysis - dars.gov.et
APLM|Apollomics Inc|Price:18.150|Chg%:-0.060 - TradingKey
Apollomics Inc (APLM) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Apollomics Inc (APLM) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Apollomics Inc Stock (APLM) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.06%
2.55%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):